Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy

Experience at a tertiary care centre in Oman

H. Farhan, A. Albulushi, A. Taqi, A. Al-Hashim, K. Al-Saidi, K. Al-Rasadi, A. Al-Mazroui, I. Al-Zakwani

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To determine the incidence and pattern of thyroid dysfunction (TD) in patients on chronic amiodarone therapy. Methods: A retrospective study which evaluated 59 patients who had received amiodarone therapy regularly for at least 12 months from a period of 3 years from October 2007 to October 2010. The patients were followed-up at the cardiac clinic at Sultan Qaboos University Hospital, Muscat, Oman. Results: The mean age of the cohort was 63 ± 13 years ranging from 27 to 98 years. Fifty-one percent (n = 30) of the pa-tients were female. There were 11 (19%) cases of thyroid dysfunction (TD). Seven (12%) patients were hypothyroid, 3 (5%) had hyperthyroidism and 1 (2%) patient had sub-clinical hypothyroidism; no cases of sub-clinical hyperthyroidism were noted. Female gender and presence of anti-thyroid peroxidase antibodies were significantly associated with amiodarone-induced hypothyroidism (p = 0.001) while age, amiodarone dose and duration of therapy were not correlated with the development of TD (all p-values > 0.05). Conclusion: Amiodarone-induced thyroid dysfunction is prevalent. Hypothyroidism was more frequent and seen more in female patients and those who had positive anti-thyroid peroxidase antibodies. Initial screening and periodic monitoring of thyroid function is mandatory for all patients on amiodarone therapy.

Original languageEnglish
Pages (from-to)122-126
Number of pages5
JournalOpen Cardiovascular Medicine Journal
Volume7
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Oman
Amiodarone
Tertiary Care Centers
Thyroid Gland
Incidence
Hypothyroidism
Iodide Peroxidase
Hyperthyroidism
Therapeutics
Antibodies
Retrospective Studies

Keywords

  • Amiodarone
  • Hyperthyroidism
  • Hypothyroidism
  • Oman
  • Thyroid diseases
  • Thyrotoxicosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy : Experience at a tertiary care centre in Oman. / Farhan, H.; Albulushi, A.; Taqi, A.; Al-Hashim, A.; Al-Saidi, K.; Al-Rasadi, K.; Al-Mazroui, A.; Al-Zakwani, I.

In: Open Cardiovascular Medicine Journal, Vol. 7, No. 1, 2013, p. 122-126.

Research output: Contribution to journalArticle

@article{877633a8ce86499c98d7e2d0e1bc559e,
title = "Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy: Experience at a tertiary care centre in Oman",
abstract = "Objective: To determine the incidence and pattern of thyroid dysfunction (TD) in patients on chronic amiodarone therapy. Methods: A retrospective study which evaluated 59 patients who had received amiodarone therapy regularly for at least 12 months from a period of 3 years from October 2007 to October 2010. The patients were followed-up at the cardiac clinic at Sultan Qaboos University Hospital, Muscat, Oman. Results: The mean age of the cohort was 63 ± 13 years ranging from 27 to 98 years. Fifty-one percent (n = 30) of the pa-tients were female. There were 11 (19{\%}) cases of thyroid dysfunction (TD). Seven (12{\%}) patients were hypothyroid, 3 (5{\%}) had hyperthyroidism and 1 (2{\%}) patient had sub-clinical hypothyroidism; no cases of sub-clinical hyperthyroidism were noted. Female gender and presence of anti-thyroid peroxidase antibodies were significantly associated with amiodarone-induced hypothyroidism (p = 0.001) while age, amiodarone dose and duration of therapy were not correlated with the development of TD (all p-values > 0.05). Conclusion: Amiodarone-induced thyroid dysfunction is prevalent. Hypothyroidism was more frequent and seen more in female patients and those who had positive anti-thyroid peroxidase antibodies. Initial screening and periodic monitoring of thyroid function is mandatory for all patients on amiodarone therapy.",
keywords = "Amiodarone, Hyperthyroidism, Hypothyroidism, Oman, Thyroid diseases, Thyrotoxicosis",
author = "H. Farhan and A. Albulushi and A. Taqi and A. Al-Hashim and K. Al-Saidi and K. Al-Rasadi and A. Al-Mazroui and I. Al-Zakwani",
year = "2013",
doi = "10.2174/1874192401307010122",
language = "English",
volume = "7",
pages = "122--126",
journal = "Open Cardiovascular Medicine Journal",
issn = "1874-1924",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy

T2 - Experience at a tertiary care centre in Oman

AU - Farhan, H.

AU - Albulushi, A.

AU - Taqi, A.

AU - Al-Hashim, A.

AU - Al-Saidi, K.

AU - Al-Rasadi, K.

AU - Al-Mazroui, A.

AU - Al-Zakwani, I.

PY - 2013

Y1 - 2013

N2 - Objective: To determine the incidence and pattern of thyroid dysfunction (TD) in patients on chronic amiodarone therapy. Methods: A retrospective study which evaluated 59 patients who had received amiodarone therapy regularly for at least 12 months from a period of 3 years from October 2007 to October 2010. The patients were followed-up at the cardiac clinic at Sultan Qaboos University Hospital, Muscat, Oman. Results: The mean age of the cohort was 63 ± 13 years ranging from 27 to 98 years. Fifty-one percent (n = 30) of the pa-tients were female. There were 11 (19%) cases of thyroid dysfunction (TD). Seven (12%) patients were hypothyroid, 3 (5%) had hyperthyroidism and 1 (2%) patient had sub-clinical hypothyroidism; no cases of sub-clinical hyperthyroidism were noted. Female gender and presence of anti-thyroid peroxidase antibodies were significantly associated with amiodarone-induced hypothyroidism (p = 0.001) while age, amiodarone dose and duration of therapy were not correlated with the development of TD (all p-values > 0.05). Conclusion: Amiodarone-induced thyroid dysfunction is prevalent. Hypothyroidism was more frequent and seen more in female patients and those who had positive anti-thyroid peroxidase antibodies. Initial screening and periodic monitoring of thyroid function is mandatory for all patients on amiodarone therapy.

AB - Objective: To determine the incidence and pattern of thyroid dysfunction (TD) in patients on chronic amiodarone therapy. Methods: A retrospective study which evaluated 59 patients who had received amiodarone therapy regularly for at least 12 months from a period of 3 years from October 2007 to October 2010. The patients were followed-up at the cardiac clinic at Sultan Qaboos University Hospital, Muscat, Oman. Results: The mean age of the cohort was 63 ± 13 years ranging from 27 to 98 years. Fifty-one percent (n = 30) of the pa-tients were female. There were 11 (19%) cases of thyroid dysfunction (TD). Seven (12%) patients were hypothyroid, 3 (5%) had hyperthyroidism and 1 (2%) patient had sub-clinical hypothyroidism; no cases of sub-clinical hyperthyroidism were noted. Female gender and presence of anti-thyroid peroxidase antibodies were significantly associated with amiodarone-induced hypothyroidism (p = 0.001) while age, amiodarone dose and duration of therapy were not correlated with the development of TD (all p-values > 0.05). Conclusion: Amiodarone-induced thyroid dysfunction is prevalent. Hypothyroidism was more frequent and seen more in female patients and those who had positive anti-thyroid peroxidase antibodies. Initial screening and periodic monitoring of thyroid function is mandatory for all patients on amiodarone therapy.

KW - Amiodarone

KW - Hyperthyroidism

KW - Hypothyroidism

KW - Oman

KW - Thyroid diseases

KW - Thyrotoxicosis

UR - http://www.scopus.com/inward/record.url?scp=84896809581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896809581&partnerID=8YFLogxK

U2 - 10.2174/1874192401307010122

DO - 10.2174/1874192401307010122

M3 - Article

VL - 7

SP - 122

EP - 126

JO - Open Cardiovascular Medicine Journal

JF - Open Cardiovascular Medicine Journal

SN - 1874-1924

IS - 1

ER -